J9205 HCPCS Level II code: Injection, irinotecan liposome, 1 mg
J9205 is the HCPCS code for “Injection, irinotecan liposome, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9205Injection, irinotecan liposome, 1 mg
Short description: Inj irinotecan liposome 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9205 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2017
Where J9205 sits
- 1J codesDrugs administered other than orally
- 2Active code J9205Injection, irinotecan liposome, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9205 mean?
J9205 is the HCPCS code for “Injection, irinotecan liposome, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9205?
CMS lists J9205’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9205
All J codesJ9199Injection, gemcitabine hydrochloride (infugem), 200 mgJ9200Injection, floxuridine, 500 mgJ9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mgJ9202Goserelin acetate implant, per 3.6 mgJ9203Injection, gemtuzumab ozogamicin, 0.1 mgJ9204Injection, mogamulizumab-kpkc, 1 mgJ9206Injection, irinotecan, 20 mgJ9207Injection, ixabepilone, 1 mgJ9208Injection, ifosfamide, 1 gramJ9209Injection, mesna, 200 mgJ9210Injection, emapalumab-lzsg, 1 mgJ9211Injection, idarubicin hydrochloride, 5 mg